NYSE · Healthcare
SHOULDER INNOVATIONS, INC. (SI)
As-reported financials and recent SEC filings for SHOULDER INNOVATIONS, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$47.3M
Net income
$-40.4M
Net margin
-85.3%
Diluted EPS
$-4.65
ROE
-28.7%
P/E (TTM)
—
Market cap
—
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2025 |
|---|---|---|
| Revenue | $47.3M | $31.6M |
| Gross profit | $36.2M | $24.3M |
| Operating income | $-26.3M | $-14.7M |
| Net income | $-40.4M | $-15.6M |
| Diluted EPS | $-4.65 | $-1.81 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →8-K2026-06-29
View on EDGAR →42026-06-29
View on EDGAR →42026-06-29
View on EDGAR →8-K2026-06-26
View on EDGAR →42026-06-16
View on EDGAR →Largest Healthcare peers
Go deeper on SI
Search SHOULDER INNOVATIONS, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.